- Home
- BBIO vs OHI Comparison
BBIO vs OHI Comparison
Compare BBIO & OHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- OHI
- Stock Information
- Founded
- BBIO 2015
- OHI N/A
- Country
- BBIO United States
- OHI United States
- Employees
- BBIO N/A
- OHI N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- OHI Real Estate Investment Trusts
- Sector
- BBIO Health Care
- OHI Real Estate
- Exchange
- BBIO Nasdaq
- OHI Nasdaq
- Market Cap
- BBIO 10.4B
- OHI 12.3B
- IPO Year
- BBIO 2019
- OHI N/A
- Fundamental
- Price
- BBIO $66.62
- OHI $39.53
- Analyst Decision
- BBIO Strong Buy
- OHI Hold
- Analyst Count
- BBIO 16
- OHI 9
- Target Price
- BBIO $65.88
- OHI $43.13
- AVG Volume (30 Days)
- BBIO 2.2M
- OHI 1.5M
- Earning Date
- BBIO 10-29-2025
- OHI 10-30-2025
- Dividend Yield
- BBIO N/A
- OHI 6.70%
- EPS Growth
- BBIO N/A
- OHI 23.41
- EPS
- BBIO N/A
- OHI 1.61
- Revenue
- BBIO $235,812,000.00
- OHI $1,114,637,000.00
- Revenue This Year
- BBIO $115.12
- OHI $12.23
- Revenue Next Year
- BBIO $65.29
- OHI $7.97
- P/E Ratio
- BBIO N/A
- OHI $24.77
- Revenue Growth
- BBIO 7.62
- OHI 14.04
- 52 Week Low
- BBIO $21.72
- OHI $35.04
- 52 Week High
- BBIO $65.00
- OHI $44.42
- Technical
- Relative Strength Index (RSI)
- BBIO 77.10
- OHI 40.61
- Support Level
- BBIO $52.75
- OHI $39.86
- Resistance Level
- BBIO $65.00
- OHI $41.00
- Average True Range (ATR)
- BBIO 2.34
- OHI 0.62
- MACD
- BBIO 1.00
- OHI -0.01
- Stochastic Oscillator
- BBIO 80.66
- OHI 26.03
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About OHI Omega Healthcare Investors Inc.
Omega Healthcare Investors Inc is a healthcare facility real estate investment trust that invests in the United States real estate markets. Omega's portfolio focuses on long-term healthcare facilities. Omega has one reportable segment consisting of investments in healthcare-related real estate properties located in the United States and the United Kingdom. Its core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs).